Clinical Trials Logo

Gastric Cancer clinical trials

View clinical trials related to Gastric Cancer.

Filter by:
  • Suspended  
  • Page 1

NCT ID: NCT05233007 Suspended - Gastric Cancer Clinical Trials

Upper GI Serial Tumour Biopsies

Start date: January 25, 2022
Phase:
Study type: Observational

This is a prospective translational research study in which tumour samples, blood samples and other biospecimens will be requested from patients with locally advanced or metastatic malignant oesophageal and gastric carcinoma. There are two parts to the study: - Part A - evaluation of serial tumour biopsies - Part B - evaluation of circulating biomarkers and other biospecimens

NCT ID: NCT05101616 Suspended - Gastric Cancer Clinical Trials

A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric Cancer

Start date: July 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

It is a single-center, open-lable, randomized controlled trial to prospectively investigate the effectiveness and safety of Camrelizumab combined with DOS regimen chemotherapy in neoadjuvant treatment of patients with locally advanced gastric cancer.

NCT ID: NCT04714983 Suspended - Breast Cancer Clinical Trials

DNX-2440 for Resectable Colorectal Liver Metastasis

Start date: February 15, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to test an experimental oncolytic adenovirus called DNX-2440 in patients with resectable multifocal (≥ 2 lesions) liver metastasis, who are scheduled to have curative-intent liver resection surgery. Up to 18 patients will receive two sequential intra-tumoral injections of DNX-2440 into a metastatic liver tumor prior to surgery for liver resection, to evaluate safety and biological endpoints across 3 dose levels (dose escalation). Upon conclusion of the dose-escalation phase, the selected safe and biologically appropriate dose will be administered using the same schema for an additional 12 patients with colorectal cancer liver metastasis (expansion cohort) using established biologic endpoints.

NCT ID: NCT04368702 Suspended - Gastric Cancer Clinical Trials

CONFIRM: Magnetic Resonance Guided Radiation Therapy

CONFIRM
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

This research is being done to determine the safety and feasibility of using a type of radiation guided by magnetic resonance imaging (MRI) and chemotherapy to treat patients with gastric and breast cancer. The name of the radiation machine involved in this study is the MRIdian Linear Accelerator.

NCT ID: NCT01342653 Suspended - Gastric Cancer Clinical Trials

Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis

HIPEC
Start date: January 2011
Phase: Phase 2
Study type: Interventional

Implementation of a curative strategy of treatment in peritoneal carcinomatosis of gastric cancer. The goal is to get 1C level of evidence (patient died with "standard" treatment, with this treatment some of them survive) in terms of disease free survival and overall survival. Methodology: prospective, phase II, multicentric in Spain. Recruitment of 50 patients(to have 31 on treatment) in three years. This strategy is based on neoadjuvant systemic plus simultaneous intraperitoneal and intravenous chemotherapy(NIPS),to treat peritoneal disease by bi-directional approach; next step is cytoreductive surgery and HIPEC. Once patients are discharged, they will follow a systemic adjuvant chemotherapy protocol.

NCT ID: NCT00568529 Suspended - Gastric Cancer Clinical Trials

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Start date: October 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and overall survival of the regimen of XELOX (Xeloda and oxaliplatin combination) in the patients with relapsed and refractory gastric cancer.

NCT ID: NCT00209729 Suspended - Gastric Cancer Clinical Trials

Phase I/II Study of Oral S-1 Plus Docetaxel in Elderly Patients With Advanced Gastric Cancer.

Start date: April 2005
Phase: Phase 1/Phase 2
Study type: Interventional

To assess the usefulness of Docetaxel plus S-1 combination chemotherapy based on the antitumor effect and survival period by performing a phase I/II study of this combination in Elderly patients with inoperable or with postoperative gastric cancer.

NCT ID: NCT00209664 Suspended - Gastric Cancer Clinical Trials

Phase II Study of Oral S-1 Plus Irinotecan in Patients With Advanced Gastric Cancer

Start date: January 2004
Phase: Phase 2
Study type: Interventional

To assess the usefulness of irinotecan plus S-1 therapy based on the antitumor effect and survival period. by performing a phase II study of this combination in patients with inoperable or with postoperative gastric cancer

NCT ID: NCT00048529 Suspended - Gastric Cancer Clinical Trials

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

Start date: September 2002
Phase: Phase 2
Study type: Interventional

This is a clinical research study of T900607-sodium to determine if it is effective and safe in treating gastric cancer and adenocarcinoma of the esophagus. Patients will be treated on a weekly basis with an intravenous injection of the study drug.